Over the past few years, the mass spectrometry-based Multi-Attribute Method (MAM) has gained traction due to its potential to streamline lab work and decrease development time. However, several barriers to adoption remain, one of which is evaluating performance of MAM vs. conventional methods.
To evaluate the performance of MAM vs conventional methods, adalimumab and. Enabling Broader Adoption of MAM: Comparison of MAM vs. Conventional Methods is an official on-demand session listing associated with BioPharma Webinars.
Visit the company-owned event page for the organizer's latest agenda, access details, availability, and registration or viewing instructions. UPCOMING provides this independent listing to help professionals discover the session and routes outbound visitors to the official company source with referral attribution.
Enabling Broader Adoption of MAM: Comparison of MAM vs. Conventional Methods is hosted by BioPharma Webinars.
Enabling Broader Adoption of MAM: Comparison of MAM vs. Conventional Methods is scheduled for Monday, April 28, 2025.
Registration or viewing is completed on BioPharma Webinars's website. UPCOMING sends visitors using referral parameters.
This is an online webinar.
The event covers SaaS.
EndedMay 29, 2026
BioPharma Webinars
EndedMay 5, 2026
BioPharma Webinars
EndedDec 5, 2025
BioPharma Webinars